| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,181 | 19,779 | 20,101 | 20,874 | | Cost of Revenue | 3,129 | 3,335 | 4,005 | 4,808 | | | Gross Profit |
-
| 16,444 | 16,096 | 16,066 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,684 | 10,012 | 9,860 | 8,335 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,451 | 1,255 | 971 | 1,763 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 5,177 | 5,265 | 5,968 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,917 | 5,177 | 5,265 | 5,968 | | Interest Expense | 1,549 | 1,471 | 1,211 | 1,398 | | Income Before Tax | 4,368 | 3,706 | 4,054 | 4,570 | | Income Tax Expense | 1,177 | 942 | 1,112 | 1,217 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,191 | 2,764 | 2,942 | 3,353 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,191 | 2,764 | 2,942 | 3,353 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,191 | $2,764 | $2,942 | $3,353 |
|
0.31% Nasdaq 
0.05%
Income Statement
